{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:43:40Z","timestamp":1788270220151,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018557","name":"Science and Technology Project of Nantong City","doi-asserted-by":"publisher","award":["JC22022022"],"award-info":[{"award-number":["JC22022022"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872853"],"award-info":[{"award-number":["81872853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["DSAD-15-363172"],"award-info":[{"award-number":["DSAD-15-363172"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bcp.2024.116233","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:54:24Z","timestamp":1713873264000},"page":"116233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-9051","authenticated-orcid":false,"given":"Dandan","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2024.116233_b0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0891988706297086","article-title":"Early-onset Alzheimer's disease is associated with greater pathologic burden","volume":"20","author":"Marshall","year":"2007","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"6238","key":"10.1016\/j.bcp.2024.116233_b0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/341144a0","article-title":"The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II","volume":"341","author":"Oltersdorf","year":"1989","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2024.116233_b0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0896-6273(90)90100-T","article-title":"Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR","volume":"4","author":"Golde","year":"1990","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116233_b0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-328X(97)00045-4","article-title":"Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes","volume":"47","author":"Rohan de Silva","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116233_b0025","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0006-291X(90)90992-V","article-title":"Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: Pre A4(695) mRNA is predominantly produced in rat and human brain","volume":"166","author":"Kang","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2024.116233_b0030","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1046\/j.1471-4159.1994.62031062.x","article-title":"Down's syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination","volume":"62","author":"Oyama","year":"1994","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.bcp.2024.116233_b0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000092315","article-title":"APP processing and the APP-KPI domain involvement in the amyloid cascade","volume":"2","author":"Menendez-Gonzalez","year":"2005","journal-title":"Neurodegener. Dis."},{"issue":"47","key":"10.1016\/j.bcp.2024.116233_b0040","doi-asserted-by":"crossref","first-page":"28257","DOI":"10.1074\/jbc.270.47.28257","article-title":"Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease","volume":"270","author":"Rockenstein","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116233_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbrainres.2003.08.022","article-title":"Amyloid precursor protein mRNA levels in Alzheimer's disease brain","volume":"122","author":"Preece","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"4957","key":"10.1016\/j.bcp.2024.116233_b0050","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.2111579","article-title":"Relation of neuronal APP-751\/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease","volume":"248","author":"Johnson","year":"1990","journal-title":"Science"},{"issue":"1\u20134","key":"10.1016\/j.bcp.2024.116233_b0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000335225","article-title":"Contribution of Kunitz protease inhibitor and transmembrane domains to amyloid precursor protein homodimerization","volume":"10","author":"Ben Khalifa","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2024.116233_b0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.410170310","article-title":"Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome","volume":"17","author":"Wisniewski","year":"1985","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116233_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/hmg\/ddl437","article-title":"The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease","volume":"16","author":"Kimura","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2024.116233_b0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41598-017-00682-y","article-title":"Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice","volume":"7","author":"Yin","year":"2017","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.bcp.2024.116233_b0075","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1093\/nar\/gkr195","article-title":"Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A","volume":"39","author":"Qian","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"42","key":"10.1016\/j.bcp.2024.116233_b0080","doi-asserted-by":"crossref","first-page":"28660","DOI":"10.1074\/jbc.M802645200","article-title":"Increased dosage of Dyrk1A alters alternative splicing factor (ASF)-regulated alternative splicing of tau in Down syndrome","volume":"283","author":"Shi","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2024.116233_b0085","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2024.116233_b0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2017.06.010","article-title":"Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes","volume":"106","author":"Garcia-Cerro","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2024.116233_b0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease","volume":"104","author":"Ryoo","year":"2008","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.bcp.2024.116233_b0100","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.neurobiolaging.2010.11.021","article-title":"Regulation of alternative splicing of tau exon 10 by 9G8 and Dyrk1A","volume":"33","author":"Ding","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"36","key":"10.1016\/j.bcp.2024.116233_b0105","doi-asserted-by":"crossref","first-page":"30497","DOI":"10.1074\/jbc.M112.355412","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine\/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion","volume":"287","author":"Yin","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2024.116233_b0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.mp.4001971","article-title":"A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms","volume":"12","author":"Donev","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2024.116233_b0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nbd.2005.12.006","article-title":"DYRKIA BAC transgenic mice show altered synaptic plasticity with learning and memory defects","volume":"22","author":"Ahn","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2024.116233_b0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1471-4159.2010.07097.x","article-title":"In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs","volume":"116","author":"Smith","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2024.116233_b0125","doi-asserted-by":"crossref","first-page":"44507","DOI":"10.1038\/srep44507","article-title":"Neuronal ELAVL proteins utilize AUF-1 as a co-partner to induce neuron-specific alternative splicing of APP","volume":"7","author":"Fragkouli","year":"2017","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.bcp.2024.116233_b0130","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1111\/j.1742-4658.2009.07346.x","article-title":"Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation","volume":"276","author":"Gockler","year":"2009","journal-title":"FEBS J."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116233_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-328X(96)00160-X","article-title":"A new quantitative solution hybridisation-RNase protection assay for APP and APLP2 mRNA","volume":"43","author":"Johnston","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116233_b0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","article-title":"Functions of Abeta, sAPPalpha and sAPPbeta: Similarities and differences","volume":"120","author":"Chasseigneaux","year":"2012","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bcp.2024.116233_b0145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/cn300094k","article-title":"Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?","volume":"3","author":"Smith","year":"2012","journal-title":"ACS Chem. Nerosci."},{"issue":"8","key":"10.1016\/j.bcp.2024.116233_b0150","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1038\/tp.2014.61","article-title":"Plasma DYRK1A as a novel risk factor for Alzheimer's disease","volume":"4","author":"Janel","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.bcp.2024.116233_b0155","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4155\/fmc-2016-0013","article-title":"DYRK1A inhibition as potential treatment for Alzheimer's disease","volume":"8","author":"Stotani","year":"2016","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116233_b0160","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bbrc.2017.11.059","article-title":"Tetrahydroxystilbene glucoside modulates amyloid precursor protein processing via activation of AKT-GSK3beta pathway in cells and in APP\/PS1 transgenic mice","volume":"495","author":"Yin","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116233_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuint.2014.08.001","article-title":"Alternative splicing regulation of APP exon 7 by RBFox proteins","volume":"78","author":"Alam","year":"2014","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.bcp.2024.116233_b0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","article-title":"APP processing is regulated by cytoplasmic phosphorylation","volume":"163","author":"Lee","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116233_b0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1750-1326-6-80","article-title":"Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes","volume":"6","author":"Judge","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.bcp.2024.116233_b0180","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.15252\/embr.201540374","article-title":"DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model","volume":"16","author":"Kurabayashi","year":"2015","journal-title":"EMBO Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:20:08Z","timestamp":1762096808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224002168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":36,"alternative-id":["S0006295224002168"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116233","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A promotes the inclusion of amyloid precursor protein exon 7","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116233"}}